#Semaglutide is an active hashtag on Bluesky. In the last 30 days, 31 people shared 40 posts with it β around 1 a day. Activity is down 62% versus the previous week, peaking on Sep 10 with 4 posts.
Tags most often used together with #Semaglutide.
docwirenews.com
FDA Approves Ozempic for Kidney Disease | Docwire News
Based on FLOW trial results, the FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.
www.newsweek.com
Ozempic works differently than previously thought, study reveals
Ozempic, Wegovy, Mounjaro and other weight loss drugs work by boosting metabolism and suppressing appetite, a new trial suggests.
www.theguardian.com
Weight-loss drugs can improve kidney health, study finds
Analysis involving more than 85,000 people showed risk of worsening function was reduced by 22%
www.ajkd.org
DEFINE_ME
pubmed.ncbi.nlm.nih.gov
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial - PubMed
Semaglutide reduces albuminuria and the risk of kidney disease progression in patients with type 2 diabetes and chronic kidney disease (CKD). We conducted a randomized placebo-controlled double-blind ...
alz-journals.onlinelibrary.wiley.com
www.foodlog.nl
Wilskracht of verlangen?
βMevrouw, u bent veel te zwaarβ, zei mijn ruggendokter plompverloren. Ik keek hem recht aan en zei: βU heeft volkomen gelijk. Dat vind ik al jaren. En nu?β¦
pharmaphorum.com
Novo Nordisk rebrands as Novo as new CEO charts turnaround
Embroiled in a fight to retain market share in weight loss and diabetes therapies, Novo Nordisk has rebranded and launched a new corporate culture.
ja.ma
Efficacy and Safety of Semaglutide According to Frailty Status
This secondary analysis of a randomized clinical trial evaluates whether frailty modifies the efficacy and safety of the GLP-1 RA semaglutide in adults with cardiovascular disease and overweight/obesity.
www.news-medical.net
Tirzepatide vs semaglutide for asthma: the difference was smaller than researchers expected
In a US multicenter electronic health record study, researchers compared tirzepatide with semaglutide in adults with asthma and type 2 diabetes, matching 8,176 patients in each treatment group. Asthma...
en.killbait.com
Semaglutide in Ozempic and Wegovy associated with 40% reduction in asthma attacks, study finds
A large real-world study presented at the European Respiratory Society Congress has found that semaglutide, the active ingredient in Ozempic and Wegovy, is linked to a nearly 40% reduction in asthma attacks for people with asthma. The research, led by Professor Chloe Bloom from Imperial College London, analyzed electronic medical records from the UK involving approximately 20,000 to 22,000 patients who had started treatment with either GLP-1 receptor agonists or sulfonylurea diabetes medications. The study revealed that patients with asthma or COPD who received GLP-1 therapies experienced fewer acute respiratory attacks compared to those on other diabetes medications. Semaglutide specifically showed the strongest effect, with a 40% reduction in asthma attacks and a 20% reduction in COPD flare-ups. While the findings are promising, researchers emphasize that these results should not change current treatment decisions for asthma or COPD, as clinical trials are needed to confirm the benefits. The study also highlights the potential connection between metabolic health and respiratory conditions, suggesting that future clinical trials should include respiratory outcomes to determine if metabolic therapies could become part of a broader approach to managing airways disease. Dr. Alexander Mathioudakis, Chair of the European Respiratory Society's Group on Airway Pharmacology and Treatment, noted that obesity and metabolic dysfunction are common in airways disease and should be addressed as part of respiratory care. The research underscores the importance of considering metabolic health in respiratory treatment strategies and supports the need for further investigation into the respiratory benefits of GLP-1 drugs.
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.